FeesSafety
Pluang+

SOL, BTC lead crypto inflows while BTC, AI, ETH see major outflows on Oct 24

Market News
24 Oct 2026
Tokenpost
View Source
Neutral
SOL, BTC lead crypto inflows while BTC, AI, ETH see major outflows on Oct 24

On October 24, cryptocurrency flows showed SOL, BTC, and XMR leading inflows with over $1 million each, including $5.31 million into SOL and $3.81 million into BTC. However, BTC also recorded the largest outflow at $38.31 million, alongside significant outflows from AI and ETH. Stablecoins like USDT and USDC absorbed substantial funds leaving cryptocurrencies, with $76.32 million flowing into USDT and $32.55 million into USDC. Additionally, fiat currencies such as USD and KRW saw inflows, indicating mixed investor movements between crypto tokens, stablecoins, and fiat money.

The story on cryptocurrency inflows and outflows offers context for readers tracking crypto market dynamics. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Oct 24, 2026 18:51 WIB: out of 50 major cryptocurrencies, 6 rose and 43 fell. Notable movers include DOT at Rp19.215 with a 1-day change of -9.41%, BAT at Rp2.878 down 8.74%, and EOS at Rp12.649 up 8.13%.

More News

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
1 hour ago
Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
1 hour ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
3 hours ago
BlackRock TCP Capital remains a sell amid structural challenges despite high dividend yield.

BlackRock TCP Capital remains a sell amid structural challenges despite high dividend yield.

BlackRock TCP Capital (TCPC) continues to face structural issues and sector headwinds, leading to a sell recommendation despite trading at a deep discount to its net asset value (NAV). The company has restructured its portfolio, including a significa...

Market News
Bearish
4 hours ago
Blockstream opens Swiss office to offer Bitcoin infrastructure consulting for European financial firms

Blockstream opens Swiss office to offer Bitcoin infrastructure consulting for European financial firms

Blockstream has opened a new office in Lugano, Switzerland, launching consulting services to help banks and asset managers design and implement Bitcoin infrastructure. The service covers technical planning, system architecture, and integration for pr...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App